TCL Archive House Committee Provides $21 Billion to NCI, Deletes Breast Cancer Earmark, Forward Funding July 2, 1993
TCL Archive Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival September 28, 2012